Parsshava R Mehta Email and Phone Number

• Modelled population data of Docetaxel to identify pharmacogenetic covariates that impacted drug clearance using NONMEM, Pirana, and R – results yet to be published. • Simulated a three-hour extended infusion regimen of Meropenem to achieve 40% of time above minimum inhibitory concentration using Phoenix NLME and PUMAS.• Data management for pharmacometric analysis using software like R.• Performed statistical analysis on GraphPad Prism to answer questions specific to the trial and collate results clinically.• Lead an enthusiastic team of 5 members while working on various projects in Oncology, focusing on therapeutic and drug development.• Design, execution, analysis, interpreting, and reporting of Phase-I clinical trial with a good understanding of ICH/GCP compliance and regulatory submissions.• Provided critical reasoning to update exclusion criteria for the next cohort of drug development following results from earlier cohorts of a Phase-I clinical trial.• Ensuring clinical trial data management and accurate data entry for analysis.• Trained in grantsmanship applications, which pulled off a 50 million grant from the Indian Council of Medical Research.• Established the Therapeutic Drug Monitoring (TDM) service in the hospital for antifungals, which provided a good source of income to the laboratory.• Trained graduate and other fellow students on the principles of Pharmacokinetics.

• Analyse prescriptions for therapeutic duplications and drug-drug interactions.• Collaborate with physicians to achieve drug dosage adjustments for paediatrics, renal and hepatic failure patients.• Clinical Trial Co-ordinator in a Phase-III clinical trial of Bevacizumab.• Chemotherapeutic admixture preparation according to the protocol.• Training physicians and nurses for scientific information on medication.• Reporting the progress of new drug molecules to the Drugs and Therapeutics Committee (D&TC).• Performing root cause analysis for medication errors in the ward.